Hepatitis B testing should be done before hepatitis C treatment due to risk of HBV reactivation
Improvements in HIV treatment and care have had no impact on rates of endstage liver disease among HIV-positive people with viral hepatitis
Many people in the US with chronic hepatitis B not being properly monitored
Ongoing hepatitis B virus replication associated with higher mortality for people with HIV
HIV/HBV co-infection linked to worse immune recovery and death, but tenofovir improves outcomes
Tenofovir alafenamide works well against hepatitis B with less effect on bones and kidneys
